According to Charles River Laboratories 's latest financial reports and stock price the company's current number of shares outstanding is 51,283,000. At the end of 2023 the company had 51,283,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 51.28 M | 0.74% |
2022 | 50.9 M | 0.86% |
2021 | 50.47 M | 1.44% |
2020 | 49.75 M | 1.8% |
2019 | 48.87 M | 1.52% |
2018 | 48.14 M | 1.7% |
2017 | 47.33 M | 0.3% |
2016 | 47.19 M | 2% |
2015 | 46.26 M | -0.41% |
2014 | 46.45 M | -1.47% |
2013 | 47.15 M | -0.87% |
2012 | 47.56 M | -5.04% |
2011 | 50.08 M | -22.16% |
2010 | 64.34 M | -0.99% |
2009 | 64.98 M | -3.25% |
2008 | 67.16 M | 0.49% |
2007 | 66.83 M | 0.62% |
2006 | 66.42 M | -6.8% |
2005 | 71.27 M | 54.58% |
2004 | 46.1 M | 1.2% |
2003 | 45.56 M | 0.8% |
2002 | 45.19 M | 4.98% |
2001 | 43.05 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 387,000,000 | 654.64% | ๐บ๐ธ USA |
SCYNEXIS SCYX | 47,891,996 | -6.61% | ๐บ๐ธ USA |
Repligen
RGEN | 55,815,666 | 8.84% | ๐บ๐ธ USA |